US prosecutors have charged two Indian nationals with allegedly importing and selling counterfeit Ozempic in America. The case centres on fake packaging, continued sales after an FDA warning, and the prospect of lengthy prison terms.

Two Indian nationals indicted in a counterfeit Ozempic smuggling scheme involving China-to-US distribution, fraud, and potential 71-year prison terms.

Two Indian nationals indicted in a counterfeit Ozempic smuggling scheme involving China-to-US distribution, fraud, and potential 71-year prison terms.